Receptor‐specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3-Reference-Cited by-同舟云学术

Receptor‐specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3

Published:2018-01-22 Issue:6 Volume:32 Page:3184-3192
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Zhang Yan¹,Liu Yanfang²,Wu Lehao¹,Fan Chao¹,Wang Zhiwei³,Zhang Xiuli²,Alachkar Amal³,Liang Xinmiao²,Civelli Olivier³

Affiliation:

1. School of Pharmacy, Shanghai Jiao Tong University Shanghai China

2. Key Laboratory of Separation Science for Analytical ChemistryKey Laboratory of Natural Medicine, Liaoning ProvinceDalian Institute of Chemical PhysicsChinese Academy of Sciences Dalian China

3. Department of PharmacologyUniversity of California, Irvine Irvine California USA

Funder

National Institutes of Health

National Institute on Drug Abuse

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201700337RR

Reference41 articles.

1. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells;Fathi Z.;J. Biol. Chem.,1993

2. Characterization of the bombesin-like peptide receptor family in primates

3. Bombesin receptor subtype-3 is expressed by the enteric nervous system and by interstitial cells of Cajal in the rat gastrointestinal tract

4. Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity

5. International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of dimerized BRS3-EP3 suppresses melanoma cell migration through coupling Gαs protein;Fundamental Research;2024-04

2. Interplay between G protein-coupled receptors and nanotechnology;Acta Biomaterialia;2023-10

3. Discovery of oridonin as a novel agonist for BRS-3;Phytomedicine;2022-06

4. Prostaglandin E2 EP receptors in cardiovascular disease: An update;Biochemical Pharmacology;2022-01